Total Payments
$65,029
2024 Payments
$3,425
Companies
46
Transactions
644
Medicare Patients
16,734
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$48,840 (75.1%)
Food & Beverage$14,422 (22.2%)
Travel$1,571 (2.4%)
Education$195.84 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,840 | 34 | 75.1% |
| Food and Beverage | $14,422 | 594 | 22.2% |
| Travel and Lodging | $1,571 | 9 | 2.4% |
| Education | $195.84 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $51,596 | 102 | $0 (2024) |
| Abbott Laboratories | $2,380 | 49 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,633 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,168 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $911.26 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $691.69 | 33 | $0 (2024) |
| Medtronic Vascular, Inc. | $559.43 | 13 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $534.59 | 29 | $0 (2024) |
| Boston Scientific Corporation | $519.45 | 22 | $0 (2024) |
| ShockWave Medical, Inc | $479.18 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,425 | 97 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($387.77) |
| 2023 | $12,667 | 123 | Actelion Pharmaceuticals US, Inc. ($9,743) |
| 2022 | $8,555 | 87 | Actelion Pharmaceuticals US, Inc. ($7,096) |
| 2021 | $6,688 | 50 | Actelion Pharmaceuticals US, Inc. ($5,699) |
| 2020 | $5,407 | 53 | Actelion Pharmaceuticals US, Inc. ($4,799) |
| 2019 | $8,791 | 91 | Actelion Pharmaceuticals US, Inc. ($7,324) |
| 2018 | $18,099 | 93 | Actelion Pharmaceuticals US, Inc. ($16,554) |
| 2017 | $1,397 | 50 | Abbott Laboratories ($498.63) |
All Payment Transactions
644 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: Heart Failure | ||||||
| 12/04/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $111.38 | General |
| Category: Vascular | ||||||
| 11/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $91.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $33.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $162.65 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/29/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $171.38 | General |
| Category: VTE | ||||||
| 10/28/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $118.95 | General |
| Category: Coronary | ||||||
| 10/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: ACURATE neo2 Aortic Valve_IC | ||||||
| 10/26/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $103.35 | General |
| Category: Endovascular | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Heart Failure | ||||||
| 10/01/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $76.22 | General |
| Category: Cardiovascular Device | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Cardio-pulmonary | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.24 | General |
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: AVVIGO_IC | ||||||
| 09/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,941 | 5,435 | $1.3M | $309,488 |
| 2022 | 32 | 3,563 | 5,214 | $1.2M | $300,565 |
| 2021 | 35 | 4,275 | 6,227 | $1.5M | $378,237 |
| 2020 | 38 | 4,955 | 7,161 | $1.6M | $412,949 |
Total Patients
16,734
Total Services
24,037
Medicare Billing
$1.4M
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 550 | $86,710 | $45,212 | 52.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 331 | 336 | $203,278 | $42,342 | 20.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 129 | 129 | $167,025 | $39,833 | 23.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 121 | 289 | $47,970 | $25,647 | 53.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 129 | 258 | $57,960 | $23,470 | 40.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 39 | 51 | $153,510 | $19,718 | 12.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 140 | 155 | $46,850 | $19,028 | 40.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 109 | 436 | $52,320 | $18,989 | 36.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 70 | 70 | $98,350 | $12,112 | 12.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 183 | 188 | $37,600 | $9,167 | 24.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 131 | 132 | $39,425 | $6,000 | 15.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $12,615 | $5,978 | 47.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 515 | 776 | $38,800 | $4,750 | 12.2% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $22,480 | $3,846 | 17.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 276 | 319 | $23,155 | $3,151 | 13.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 27 | $5,745 | $3,117 | 54.3% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 28 | 30 | $42,150 | $2,789 | 6.6% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $23,885 | $2,728 | 11.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $40,015 | $2,672 | 6.7% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 34 | 72 | $7,920 | $2,318 | 29.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 32 | 36 | $12,060 | $2,266 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 198 | 268 | $4,020 | $2,228 | 55.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 114 | 124 | $8,680 | $1,601 | 18.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 130 | 137 | $5,480 | $1,294 | 23.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 75 | 284 | $8,520 | $1,184 | 13.9% |
About Dr. Maxwell Prempeh, MD
Dr. Maxwell Prempeh, MD is a Cardiovascular Disease healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992867592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maxwell Prempeh, MD has received a total of $65,029 in payments from pharmaceutical and medical device companies, with $3,425 received in 2024. These payments were reported across 644 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,840).
As a Medicare-enrolled provider, Prempeh has provided services to 16,734 Medicare beneficiaries, totaling 24,037 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Cartersville, GA
- Active Since 12/14/2006
- Last Updated 09/21/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992867592
Products in Payments
- UPTRAVI (Drug) $24,272
- OPSUMIT MACITENTAN (Drug) $10,728
- OPSUMIT (Drug) $7,025
- LifeVest (Device) $1,633
- OPTIS (Device) $1,217
- XARELTO (Drug) $1,168
- ENTRESTO (Drug) $732.85
- Resolute (Device) $459.64
- Repatha (Biological) $370.78
- Barostim Neo System (Device) $364.73
- Adempas (Drug) $341.92
- BRILINTA (Drug) $291.18
- PCI Optimization (Device) $279.67
- ELIQUIS (Drug) $264.87
- VERQUVO (Drug) $260.06
- Ranexa (Drug) $234.16
- FARXIGA (Drug) $212.73
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $200.75
- FLOWTRIEVER CATHETER, S (Device) $188.75
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $180.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cartersville
Digant Bhatt, Md, MD
Cardiovascular Disease — Payments: $9,793
Cardiovascular Disease $9,793
Ryan Chizner, Do, DO
Cardiovascular Disease — Payments: $9,242
Cardiovascular Disease $9,242
Rajeeve Subbiah, Md, MD
Cardiovascular Disease — Payments: $5,304
Cardiovascular Disease $5,304
Dr. Suresh Ramamurthy, Md, MD
Cardiovascular Disease — Payments: $5,248
Cardiovascular Disease $5,248
Godly Jack, Md, MD
Cardiovascular Disease — Payments: $2,439
Cardiovascular Disease $2,439
Ravinder Reddy, M.d, M.D
Cardiovascular Disease — Payments: $83.04
Cardiovascular Disease $83.04